Drugs.com

MARCH 24, 2025

Centers for Disease Control and Prevention's (CDC) vaccine safety site has been taken down on orders from health secretary Robert F. MONDAY, March 24, 2025 -- A fake web page designed to look like the U.S. Kennedy Jr.The site was linked to.

Vaccine 263

Vaccine Disease 263

Drugs.com

AUGUST 21, 2023

21, 2023 -- Certain adult vaccines, including shingles and pneumonia shots, may also help seniors fight off Alzheimer's disease, new research reveals. Prior vaccination with the shingles vaccine, pneumococcus vaccine or the tetanus and. MONDAY, Aug.

Vaccine 246

Vaccine Disease Research 246

Science Daily: Pharmacology News

AUGUST 31, 2023

A new study found that more than half of people who own dogs expressed some level of canine vaccine hesitancy -- i.e. skepticism about vaccinating their pets against rabies and other diseases.

Vaccine 253

Vaccine Disease 253

Drugs.com

JUNE 29, 2023

THURSDAY, June 29, 2023 -- Americans ages 60 and up can get their vaccine for respiratory syncytial virus (RSV) this fall, the U.S. Centers for Disease Control and Prevention announced Thursday. On Thursday, Dr. Rochelle Walensky, the outgoing CDC.

Vaccine 290

Vaccine Virus Disease 290

Drugs.com

SEPTEMBER 7, 2023

7, 2023 -- While it doesn't prevent infection altogether, new research shows the mpox vaccine does reduces the severity of disease in those who fall ill from the virus. THURSDAY, Sept. An international team of scientists found that those people who.

Vaccine 214

Vaccine Virus International Disease 214

Drugs.com

APRIL 17, 2025

THURSDAY, April 17, 2025 A panel of federal health experts on Wednesday recommended expanded vaccine options for several diseases, including respiratory syncytial virus (RSV), meningitis and a mosquito-borne illness called chikungunya.The panel, k.

Vaccine 170

Vaccine Virus Disease 170

Drugs.com

OCTOBER 27, 2023

26, 2023 – High-risk men should still get their mpox vaccinations even after the ongoing outbreak ends, advisors to the U.S. Centers for Disease Control and Prevention recommended Wednesday. THURSDAY, Oct. That vulnerable group includes.

Vaccine 203

Vaccine Disease 203

Drugs.com

OCTOBER 27, 2023

26, 2023 -- A new vaccine recommended Wednesday by independent advisers to the U.S. Centers for Disease Control and Prevention could provide more comprehensive protection from meningitis. THURSDAY, Oct. The shot would protect against five types of.

Vaccine 189

Vaccine Disease 189

Drugs.com

NOVEMBER 22, 2024

22, 2024 -- Worn down by pandemic-era vaccine overload, many Americans are ignoring pleas by health officials to get immunized against the flu and COVID-19, new data shows.According to U.S. Centers for Disease Control and Prevention. FRIDAY, Nov.

Vaccine 162

Vaccine Disease 162

Drugs.com

FEBRUARY 18, 2025

Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active immunization against invasive meningococcal disease (IMD), according to a press release from. TUESDAY, Feb. 18, 2025 -- The U.S.

FDA Approval 147

FDA Approval Vaccine FDA Disease 147

BioPharma Drive: Drug Pricing

OCTOBER 3, 2023

The French vaccine giant will pay J&J $175 million to share rights to the experimental inoculation, which is currently in Phase 3 testing.

Vaccine 144

Vaccine Disease 144

BioPharma Drive: Drug Pricing

FEBRUARY 21, 2024

The Danish company scrapped a vaccine in Phase 1 testing and will exit oncology altogether, focusing instead on infectious disease research.

Vaccine 146

Vaccine Disease Research 146

SCIENMAG: Medicine & Health

JULY 30, 2023

Research Highlights: A novel vaccine that targets a protein involved in Alzheimer’s disease helped eliminate toxic cells in mice with the condition. After vaccination, the mice had fewer amyloid plaques and less inflammation in brain tissue and showed improvement in behavior and awareness. Embargoed until 12 p.m.

Vaccine 96

Vaccine Disease Research 96

Drugs.com

AUGUST 24, 2023

24, 2023 -- For the first time in a decade, the rate at which American adolescents received the human papillomavirus (HPV) vaccine has not increased, new data show. Centers for Disease Control and. THURSDAY, Aug. Current guidelines from the U.S.

Vaccine 130

Vaccine Disease 130

Drugs.com

JUNE 29, 2023

THURSDAY, June 29, 2023 -- Americans ages 60 and up can get their vaccine for respiratory syncytial virus (RSV) this fall, the U.S. Centers for Disease Control and Prevention announced Thursday. On Thursday, Dr. Rochelle Walensky, the outgoing CDC.

Vaccine 130

Vaccine Virus Disease 130

PPD

JUNE 24, 2024

In the realm of vaccine development, mega trials — studies enrolling 5,000 subjects or more — have been instrumental in the fight against many pathogens, including influenza, rotavirus, malaria, RSV and most recently in the rapid development of vaccines against COVID-19.

Vaccine 97

Vaccine Trials Clinical Trials Laboratories 97

DrugBank

MARCH 12, 2025

The COVID-19 pandemic brought mRNA to global prominence by developing highly effective vaccines by Moderna and Pfizer-BioNTech. However, mRNA technology is not limited to infectious diseases. However, mRNA technology has introduced new possibilities, particularly in developing personalized cancer vaccines and combination therapies.

Vaccine 97

Vaccine Treatment Clinical Trials Therapies 97

Drug Discovery Today

JULY 26, 2020

New state-of-the-art centre to scale up COVID-19 vaccine and gene therapy manufacturing gets £100m investment Additional £4.7m

Vaccine 113

Vaccine Therapies Disease 113

Drug Target Review

AUGUST 11, 2023

In a new development, a recent paper published in Biology Methods & Protocols by Oxford University Press has highlighted a promising avenue for enhancing vaccine efficacy against infectious pathogens like the COVID-19 virus. The implications of this finding are far-reaching, as it holds the potential to revolutionize vaccine design.

Vaccine 98

Vaccine Immune Response Bioinformatics Virus 98

Drugs.com

JUNE 12, 2023

MONDAY, June 12, 2023 -- Hepatitis C can ruin your liver, and there's no vaccine to prevent it, but you can take steps to lower your chances of infection. Centers for Disease Control and Prevention, over 2 million U.S. According to the U.S.

Vaccine 113

Vaccine Disease 113

Chemical Biology and Drug Design

NOVEMBER 13, 2023

Challenges involved in vaccines formulation were also featured. Use of computational methods and models for vaccine development has revolutionized the traditional methods of vaccine development. Main role of mRNA vaccines in the COVID-19 challenge was discussed.

Vaccine 100

Vaccine Laboratories RNA Clinical Development 100

SCIENMAG: Medicine & Health

DECEMBER 14, 2023

WHAT: An effective HIV vaccine may need to prompt strong responses from immune cells called CD8+ T cells to protect people from acquiring HIV, according to a new study from researchers at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and colleagues.

Vaccine 95

Vaccine Research Disease 95

SCIENMAG: Medicine & Health

JULY 27, 2023

OVX836 demonstrated positive safety and immunogenicity data across three dose levels A notable signal of protection of 84% was observed against symptomatic influenza infection Lyon, France – July 28, 2023 – Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating infectious viruses, today (..)

Vaccine 65

Vaccine Disease Virus 65

SCIENMAG: Medicine & Health

AUGUST 20, 2023

Research at a Glance: A Murdoch Children’s Research Institute-led review has found COVID-19 vaccines are effective against severe cases of the disease in children and adolescents.

Vaccine 75

Vaccine Virus Disease Research 75

SCIENMAG: Medicine & Health

JULY 24, 2023

Centers for Disease Control and Prevention’s VISION Network, has determined both the number of adults needed to be vaccinated to prevent one COVID-19 associated hospitalization […] An analysis of real-world data from more than 1.2

Hospitals 84

Hospitals Vaccine Disease 84

SCIENMAG: Medicine & Health

MARCH 21, 2024

In a mouse study, UCLA researchers tested a vaccine against the bacterium that causes melioidosis and found it was highly protective against the disease, which is endemic in many tropical areas, causing approximately 165,000 cases with 89,000 fatalities around the world each year. Credit: Photo courtesy of Christopher T.

Vaccine 60

Vaccine Disease Research 60

The Pharma Data

MAY 5, 2022

In animal studies that mimic human exposures, an investigational COVID vaccine designed to be taken orally not only protects the host, but also decreases the airborne spread of the virus to other close contacts. The human vaccine is designed to be taken as a pill. The study, led by Duke researcher Stephanie N. Langel, Ph.D.,

Vaccine 52

Vaccine Disease Virus Science 52

PerkinElmer

MAY 28, 2020

Time is of the essence when it comes to the development of a vaccine for the novel infectious disease in our current pandemic. The world has changed due to its impact – and the race to discover a vaccine is crucial for our return to normalcy.

Vaccine 52

Vaccine Disease Virus Small Molecule 52

The Pharma Data

SEPTEMBER 30, 2021

Anderson Professor of Chemical and Biomolecular Engineering, and his colleagues, are reporting in iScience the event of an intranasal subunit vaccine that gives durable local immunity against inhaled pathogens. A fundamental limitation of intramuscular vaccines is that they’re not designed to elicit mucosal immunity.

Vaccine 52

Vaccine Disease Immune Response Virus 52

Eye on FDA

DECEMBER 15, 2021

We now have multiple vaccines – mRNA and traditional in the U.S. We have the emergence of monoclonal antibodies and protease inhibitors being utilized or being considered as treatments for various stages of disease. However there is also an alarming rise among people who have completed their primary vaccination.

Vaccine 72

Vaccine Nurses Virus Treatment 72

The Pharma Data

APRIL 26, 2022

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and Pfizer Inc. Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and Pfizer Inc. NYSE: PFE) today reported positive Phase 2 pediatric data for their Lyme disease vaccine candidate, VLA15.

Vaccine 52

Vaccine Disease Protein Expression Trials 52

The Pharma Data

MARCH 8, 2021

Valneva SE (“Valneva”), a specialty vaccine company focused on prevention of diseases with major unmet needs, and Pfizer Inc. It will compare the three-dose vaccination schedule (Month 0-2-6) with a two-dose schedule (Month 0-6). “We We are excited to be part of the Lyme disease vaccine development program with Valneva.

Vaccine 52

Vaccine Disease Protein Expression Trials 52

SCIENMAG: Medicine & Health

FEBRUARY 14, 2024

WHAT: Women who receive an mRNA-based COVID-19 vaccination or booster during pregnancy can provide their infants with strong protection against symptomatic COVID-19 infection for at least six months after birth, according to a study from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

Vaccine 72

Vaccine Disease 72

The Pharma Data

SEPTEMBER 3, 2020

Johnson & Johnson Announces that Janssen’s COVID-19 Investigational Vaccine Candidate Prevents Severe Clinical Disease in Pre-clinical Studies. Johnson & Johnson Announces that Janssen’s COVID-19 Investigational Vaccine Candidate Prevents Severe Clinical Disease in Pre-clinical Studies.

Vaccine 52

Vaccine Disease Immune Response Pharmaceutical Companies 52

SCIENMAG: Medicine & Health

JULY 25, 2023

Scientists can use this new algorithm to compare data from vastly different experiments and better predict how individuals may respond to disease. LA JOLLA, CA—Immune system researchers have designed a computational tool to boost pandemic preparedness.

Vaccine 85

Vaccine Disease Research 85

SCIENMAG: Medicine & Health

JUNE 12, 2023

Peer-reviewed / Randomised Controlled Trial / People Study of healthy US adults found that a single dose of the VLA1553 vaccine candidate was generally safe, well tolerated and provokes an immune response.

Immune Response 66

Immune Response Vaccine Trials Disease 66

The Pharma Data

APRIL 14, 2021

The product’s early Marek’s disease onset of immunity from five days of age provides full protection of broilers, layers and breeders against the most virulent Marek’s disease virus strains. Its purpose is to provide poultry producers with cutting-edge technology in terms of Marek’s disease protection.

Vaccine 52

Vaccine Disease Virus Engineering 52